HuagongsheHuagongshe Chemistry Print Report · For research reference only
Piperazine, 1-(3-chloropropyl)-4-phenyl- → methyl 3-oxo-[3-(4-phenylpiperazin-1-yl)propyl]-3,4-dihydro-2H-1,5-benzoxathiepine-4-carboxylate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Piperazine, 1-(3-chloropropyl)-4-phenyl- | HCID 139197 | — |
| Reactant | HCID 13803747 | HCID 13803747 | — |
| Product | methyl 3-oxo-[3-(4-phenylpiperazin-1-yl)propyl]-3,4-dihydro-2H-1,5-benzoxathiepine-4-carboxylate | HCID 19434348 | — |
Reaction Steps
By the same procedure as described in Example 1, methyl 3-oxo-3,4-dihydro-2H-1,5-benzoxathiepin-4-carboxylate as obtained in Reference Example 24 is allowed to undergo condensation with 3-(4-phenylpiperazin-1-yl)propyl chloride, and methyl 3-oxo-[3-(4-phenylpiperazin-1-yl)propyl]-3,4-dihydro-2H-1,5-benzoxathiepin-4-carboxylate is isolated as the hydrochloride salt. Recrystallization from methanol produces white crystals, m.p. of 176°-178° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04751316 |
| Source dataset | uspto-grants-1988_06 |
| ORD ID | ord-a8e57776bcef4b1fb1c9bfce5c19e76a |
| Source note | uspto-grants-1988_06 |